Dems unveil bill for Medicare to negotiate drug prices

Dems unveil bill for Medicare to negotiate drug prices
© Greg Nash

Democrats on Thursday unveiled a bill to allow Medicare to negotiate drug prices, a key part of their agenda to lower pharmaceutical costs.

Sen. Sherrod BrownSherrod Campbell BrownSchiff sparks blowback with head on a 'pike' line Sunday shows - All eyes on Senate impeachment trial Senate Democrat: 'Fine' to hear from Hunter Biden MORE (D-Ohio), who is considering a presidential run, and Rep. Lloyd DoggettLloyd Alton DoggettGreen says House shouldn't hold impeachment articles indefinitely Appeals court strikes ObamaCare mandate, sends case back to lower court House passes sweeping Pelosi bill to lower drug prices MORE (D-Texas), the chairman of the House Ways and Means Health Subcommittee, led the announcement at a press conference on Thursday.

ADVERTISEMENT
“What we're really doing today is just calling on President TrumpDonald John TrumpKaine: Obama called Trump a 'fascist' during 2016 campaign Kaine: GOP senators should 'at least' treat Trump trial with seriousness of traffic court Louise Linton, wife of Mnuchin, deletes Instagram post in support of Greta Thunberg MORE to listen to candidate Trump,” Doggett said, pointing out that Trump supported Medicare negotiating drug prices in 2016 before backing off the idea.

While the odds are long the measure can get through the GOP-controlled Senate, Brown said he hoped a strong vote in the House would “put the pressure on [Senate Majority Leader] Mitch McConnellAddison (Mitch) Mitchell McConnellSchumer: Trump's team made case for new witnesses 'even stronger' Trump, Democrats risk unintended consequences with impeachment arguments CNN's Axelrod says impeachment didn't come up until 80 minutes into focus group MORE.”

Other lawmakers said they hoped that if Trump came out in support of the bill, it would also pressure Senate Republicans.

Trump has put forward other ideas on drug pricing, some of which have received some Democratic support but that Democrats generally say do not go far enough.

Doggett said that, even in the House, the path forward for the bill remains unclear, given that committees are just beginning to hold hearings on the drug-pricing issue and there are multiple different bills on the topic.

Lowering drug prices was a key issue in last year’s campaign, and several newly elected Democrats, including Reps. Katie Porter (Calif.) and Andy Kim (N.J.), touted the bill at the press conference Thursday.

Rep. Peter WelchPeter Francis WelchProviding more information on the prescription drug supply chain will help lower costs for all Impeachment hearing breaks into laughter after Democrat contrasts it to Hallmark movie Diplomat ties Trump closer to Ukraine furor MORE (D-Vt.) recalled his meeting with Trump in 2017 to discuss drug prices, saying the president expressed support for drug price negotiation in that meeting but never followed up.

“He said all the right things,” Welch said. “I thought I was meeting with [Sen.] Bernie SandersBernie SandersKaine: Obama called Trump a 'fascist' during 2016 campaign Des Moines Register endorses Elizabeth Warren as Democratic presidential nominee Sanders faces lingering questions about appeal to women voters MORE.”